|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.57 USD | -1.57% |
|
-1.88% | +11.35% |
| Mar. 15 | RBC Cuts Price Target on aTyr Pharma to $16 From $19, Keeps Outperform Rating, Speculative Risk Qualifier | MT |
| Mar. 14 | Transcript : ATyr Pharma, Inc., Q4 2023 Earnings Call, Mar 14, 2024 |
aTyr Pharma, Inc.(NasdaqCM:LIFE) added to Russell Microcap Growth Index
| 1st Jan change | Capi. | |
|---|---|---|
| +11.35% | 107M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
ATYR PHARMA, INC. 
